Jump to content
Knowledge Hub

MHRA - ICH M15 Model Informed Drug Development (MIDD) Guideline

15th January 2025

MHRA - ICH M15 Model Informed Drug Development (MIDD) Guideline

The International Council for Harmonisation (ICH) M15 Model informed Drug development (MIDD) Guideline has reached Step 2b and is available for public consultation.  As a clinical pharmacology assessor at the UK Medicines and Healthcare products Regulatory Agency (MHRA), Essam was involved with the development of this guidance.

View Blog

Back to Recent News

Share

Virtual Event Platform